Difference between revisions of "MRE Biomarker Ctte"
Jump to navigation
Jump to search
| Line 10: | Line 10: | ||
*focusing on issues important to specific reproducibility | *focusing on issues important to specific reproducibility | ||
| − | == | + | ==Meetings== |
| − | *[[Media:2016_11-07_QIBA_MRE_BC_Call_Summary-FINAL.pdf| | + | |
| + | '''Approved call summaries:''' | ||
| + | *[[Media:2016_11-07_QIBA_MRE_BC_Call_Summary-FINAL.pdf|November 7, 2016]] | ||
'''''[[MRE BC Call Summaries Archive]]''''' | '''''[[MRE BC Call Summaries Archive]]''''' | ||
Revision as of 20:27, 22 November 2017
- Co-chairs: Richard L. Ehman, MD; Patricia Cole, PhD, MD
- Secretary: Susan Weinmann
Project Snapshot
The MRE Biomarker Committee seeks to develop a quantitative Profile for MRE.
MRE Profile to be data-driven:
- focusing on the characterization of bias and precision in MRE measurement targets for achieving these measurements
- focusing on issues important to specific reproducibility
Meetings
Approved call summaries: